|
Stratifying stroke risk to guide antithrombotic therapy
|
|
|
No evidence that AF type significantly impacts stroke risk
|
|
|
Stroke Risk in AF Working Group
|
|
|
Different schemes designed to stratify stroke risk
|
|
|
Differences in risk stratification schemes
|
|
|
CHADS2 is the most recognized risk stratification scheme
|
|
|
ACCF/AHA/HRS 2011 and ACCP 2008 guidelines
|
|
|
CHA2DS2-VASc: a further refinement of CHADS2
|
|
|
ESC 2010 guidelines: based on CHADS2 and CHA2DS2-VASc
|
|
|
Many stroke risk factors are also risk factors for bleeding
|
|
|
1-year risk of major bleeding increases with HAS-BLED score
|
|
|
ATRIA: a risk scheme to predict warfarin-associated haemorrhage
|
|
Share this page with your colleagues and friends: